Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
3(33%)
Results Posted
40%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_3
3
33%
Ph phase_4
2
22%
Ph not_applicable
2
22%
Ph phase_2
2
22%

Phase Distribution

0

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
3(33.3%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Recruiting2
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (22.2%)
Phase 33 (33.3%)
Phase 42 (22.2%)
N/A2 (22.2%)

Trials by Status

active_not_recruiting111%
terminated111%
completed556%
recruiting222%

Recent Activity

3 active trials
Showing 5 of 9
active_not_recruitingphase_3

Descemet Endothelial Thickness Comparison Trial I

NCT05289661
recruitingphase_3

Parasitic Ulcer Treatment Trial

NCT06213649
terminatedphase_2

Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes

NCT03586284
completednot_applicable

Pharmacological Modulation of Peripheral Nerve Excitability

NCT06312254
completedphase_3

Steroids and Cross-linking for Ulcer Treatment

NCT04097730
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05289661Phase 3

Descemet Endothelial Thickness Comparison Trial I

Active Not Recruiting
NCT06213649Phase 3

Parasitic Ulcer Treatment Trial

Recruiting
NCT03586284Phase 2

Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes

Terminated
NCT06312254Not Applicable

Pharmacological Modulation of Peripheral Nerve Excitability

Completed
NCT04097730Phase 3

Steroids and Cross-linking for Ulcer Treatment

Completed
NCT05558007Phase 2

Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients

Recruiting
NCT03703895Phase 4

A Study for a Topical Medication Versus Placebo in Patients With Hand Dermatitis

Completed
NCT04597502Not Applicable

The Effects of Terminalia Chebula Fruit Extract on the Gut Microbiome and Skin Biophysical Properties

Completed
NCT02570841Phase 4

Pain Thresholds Under High-dose Topical Capsaicin

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9